In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday its chief executive was stepping down in the wake of "market challenges".

Discover why Novo Nordisk A/S' undervalued shares present a buying opportunity, with strong sales growth, profitability, and ...

Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...

Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has ...

Novo Nordisk's CEO, Lars Fruergaard Jorgensen, will step down amidst market challenges and a significant stock price drop, ...

Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight ...

The cost of illegal immigration is a hot-button issue – and Democrats have a wide range of reactions. In this video, we break down how Democratic leaders and voters are responding to the economic, ...

The maker of Ozempic and Wegovy expects lower sales and profit growth this year despite recent victories against compounders.

The well-known diet program says it will remain "fully operational" during the reorganization process, with no impact to ...

Jeremy Clarkson and Amy Schumer have been very open about their experiences with Ozempic in the past, and both have experienced the same brutal side effect. The drug has been in headlines recently as ...

Executives commonly sell shares through trading plans “for financial and tax planning purposes ... this announcement does not directly impact your subscription.” Her refill would come ...